Showing results (51-60 of 72) with videos related to
Sort By:
Pageof 8
JCI Insight|January 4, 2024
Macrophage RAGE activation is proinflammatory in NASHGopanandan Parthasarathy, Amy S Mauer, Naresh Golla, et al.Annals of Surgery|June 23, 2025
Development of the Perihilar Cholangiocarcinoma Risk Estimation of Tumor Recurrence After Transplant (PRETREAT) ScoreZhihao Li, Timucin Taner, John E Eaton, et al.Journal of Hepatology|March 8, 2024
Syngeneic murine models with distinct immune microenvironments represent subsets of human intrahepatic cholangiocarcinomaJennifer L Tomlinson, Binbin Li, Jingchun Yang, et al.FEBS Open Bio|September 19, 2024
YAP-TEAD inhibition is associated with upregulation of an androgen receptor mediated transcription program providing therapeutic escapeRoberto Alva-Ruiz, Ryan D Watkins, Jennifer L Tomlinson, et al.American Journal of Clinical Pathology|September 4, 2020
Molecular and Immunohistochemical Analysis of Mucinous Cystic Neoplasm of the LiverBenjamin J Van Treeck, Mira Lotfalla, Thomas W Czeczok, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 5, 2024
Neoadjuvant therapy leads to objective response in intrahepatic cholangiocarcinomaBenjamin J Van Treeck, Maria C Olave, Ryan D Watkins, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 24, 2024
WITHDRAWN: Neoadjuvant therapy leads to objective response in intrahepatic cholangiocarcinomaBenjamin J Van Treeck, Maria C Olave, Ryan D Watkins, et al.Hepatology (Baltimore, Md.)|February 10, 2025
Aptamer-directed, nanovesicle-mediated targeting of undruggable molecules in preclinical cholangiocarcinoma modelsMincheng Yu, Jack W Sample, Irene K Yan, et al.Cellular and Molecular Gastroenterology and Hepatology|February 9, 2025
Congestion Enriches Intra-hepatic Macrophages Through Reverse Zonation of CXCL9 in Liver Sinusoidal Endothelial CellsSiyuan Ma, Nawras W Habash, Mrunal K Dehankar, et al.Biorxiv : the Preprint Server for Biology|February 6, 2026
Multiomics-driven discovery of predictive biomarkers and strategies to overcome resistance to SFK-YAP inhibition in cholangiocarcinomaHendrien Kuipers, Danielle M Carlson, Erik Jessen, et al.Pageof 8